Higher fibrosis-4 score, AST, ALT, WC and WHR values were also observed in women with evidence of advanced fibrosis, with a mean age 6 years older than those with NAFLD without advanced fibrosis (Supplementary Table S3). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.